Global and United States Kidney Cancer Drugs Market Insights, Forecast to 2027

Global and United States Kidney Cancer Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Kidney Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Kidney Cancer Drugs Market Size Growth Rate by Type
1.2.2 Angiogenesis Inhibitors
1.2.3 mTOR Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine Immunotherapy (IL-2)
1.3 Market by Application
1.3.1 Global Kidney Cancer Drugs Market Size Growth Rate by Application
1.3.2 Renal Cell Carcinoma (RCC)
1.3.3 Transitional Cell Carcinoma (TCC)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Kidney Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Kidney Cancer Drugs Revenue 2016-2027
2.1.2 Global Kidney Cancer Drugs Sales 2016-2027
2.2 Global Kidney Cancer Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Kidney Cancer Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Kidney Cancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Kidney Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Kidney Cancer Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Kidney Cancer Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Kidney Cancer Drugs Revenue Forecast by Region (2022-2027)
3 Global Kidney Cancer Drugs Competitor Landscape by Players
3.1 Global Top Kidney Cancer Drugs Manufacturers by Sales
3.1.1 Global Kidney Cancer Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Kidney Cancer Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Kidney Cancer Drugs Manufacturers by Revenue
3.2.1 Key Kidney Cancer Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Kidney Cancer Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Kidney Cancer Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Kidney Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Kidney Cancer Drugs Revenue in 2020
3.2.6 Global Kidney Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Kidney Cancer Drugs Price by Manufacturers
3.4 Global Kidney Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Kidney Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Kidney Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Kidney Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Kidney Cancer Drugs Market Size by Type (2016-2021)
4.1.1 Global Kidney Cancer Drugs Sales by Type (2016-2021)
4.1.2 Global Kidney Cancer Drugs Revenue by Type (2016-2021)
4.1.3 Kidney Cancer Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Kidney Cancer Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Kidney Cancer Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Kidney Cancer Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Kidney Cancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Kidney Cancer Drugs Market Size by Application (2016-2021)
5.1.1 Global Kidney Cancer Drugs Sales by Application (2016-2021)
5.1.2 Global Kidney Cancer Drugs Revenue by Application (2016-2021)
5.1.3 Kidney Cancer Drugs Price by Application (2016-2021)
5.2 Kidney Cancer Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Kidney Cancer Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Kidney Cancer Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Kidney Cancer Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Kidney Cancer Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Kidney Cancer Drugs Sales YoY Growth 2016-2027
6.1.2 United States Kidney Cancer Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Kidney Cancer Drugs Market Share in Global Market 2016-2027
6.2 United States Kidney Cancer Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Kidney Cancer Drugs Players by Sales (2016-2021)
6.2.2 United States Top Kidney Cancer Drugs Players by Revenue (2016-2021)
6.3 United States Kidney Cancer Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Kidney Cancer Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Kidney Cancer Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Kidney Cancer Drugs Price by Type (2016-2021)
6.4 United States Kidney Cancer Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Kidney Cancer Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Kidney Cancer Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Kidney Cancer Drugs Price Forecast by Type (2022-2027)
6.5 United States Kidney Cancer Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Kidney Cancer Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Kidney Cancer Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Kidney Cancer Drugs Price by Application (2016-2021)
6.6 United States Kidney Cancer Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Kidney Cancer Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Kidney Cancer Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Kidney Cancer Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Kidney Cancer Drugs Market Size YoY Growth 2016-2027
7.2 North America Kidney Cancer Drugs Market Facts & Figures by Country
7.2.1 North America Kidney Cancer Drugs Sales by Country (2016-2021)
7.2.2 North America Kidney Cancer Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Kidney Cancer Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Kidney Cancer Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Kidney Cancer Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Kidney Cancer Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Kidney Cancer Drugs Market Size YoY Growth 2016-2027
9.2 Europe Kidney Cancer Drugs Market Facts & Figures by Country
9.2.1 Europe Kidney Cancer Drugs Sales by Country (2016-2021)
9.2.2 Europe Kidney Cancer Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Kidney Cancer Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Kidney Cancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Kidney Cancer Drugs Sales by Country (2016-2021)
10.2.2 Latin America Kidney Cancer Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Kidney Cancer Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Kidney Cancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Kidney Cancer Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Kidney Cancer Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Kidney Cancer Drugs Products Offered
12.1.5 Bayer Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Description and Business Overview
12.2.3 Roche Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche Kidney Cancer Drugs Products Offered
12.2.5 Roche Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Description and Business Overview
12.3.3 GlaxoSmithKline Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GlaxoSmithKline Kidney Cancer Drugs Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Kidney Cancer Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Kidney Cancer Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 Abbott Laboratories
12.6.1 Abbott Laboratories Corporation Information
12.6.2 Abbott Laboratories Description and Business Overview
12.6.3 Abbott Laboratories Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abbott Laboratories Kidney Cancer Drugs Products Offered
12.6.5 Abbott Laboratories Recent Development
12.7 Active Biotech
12.7.1 Active Biotech Corporation Information
12.7.2 Active Biotech Description and Business Overview
12.7.3 Active Biotech Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Active Biotech Kidney Cancer Drugs Products Offered
12.7.5 Active Biotech Recent Development
12.8 Amgen
12.8.1 Amgen Corporation Information
12.8.2 Amgen Description and Business Overview
12.8.3 Amgen Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Amgen Kidney Cancer Drugs Products Offered
12.8.5 Amgen Recent Development
12.9 Argos Therapeutics
12.9.1 Argos Therapeutics Corporation Information
12.9.2 Argos Therapeutics Description and Business Overview
12.9.3 Argos Therapeutics Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Argos Therapeutics Kidney Cancer Drugs Products Offered
12.9.5 Argos Therapeutics Recent Development
12.10 ArQule
12.10.1 ArQule Corporation Information
12.10.2 ArQule Description and Business Overview
12.10.3 ArQule Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 ArQule Kidney Cancer Drugs Products Offered
12.10.5 ArQule Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer Kidney Cancer Drugs Products Offered
12.11.5 Bayer Recent Development
12.12 Bionomics
12.12.1 Bionomics Corporation Information
12.12.2 Bionomics Description and Business Overview
12.12.3 Bionomics Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bionomics Products Offered
12.12.5 Bionomics Recent Development
12.13 Bristol-Myers Squibb
12.13.1 Bristol-Myers Squibb Corporation Information
12.13.2 Bristol-Myers Squibb Description and Business Overview
12.13.3 Bristol-Myers Squibb Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Bristol-Myers Squibb Products Offered
12.13.5 Bristol-Myers Squibb Recent Development
12.14 Cerulean Pharma
12.14.1 Cerulean Pharma Corporation Information
12.14.2 Cerulean Pharma Description and Business Overview
12.14.3 Cerulean Pharma Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cerulean Pharma Products Offered
12.14.5 Cerulean Pharma Recent Development
12.15 Exelixis
12.15.1 Exelixis Corporation Information
12.15.2 Exelixis Description and Business Overview
12.15.3 Exelixis Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Exelixis Products Offered
12.15.5 Exelixis Recent Development
12.16 Genentech
12.16.1 Genentech Corporation Information
12.16.2 Genentech Description and Business Overview
12.16.3 Genentech Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Genentech Products Offered
12.16.5 Genentech Recent Development
12.17 immatics biotechnologies
12.17.1 immatics biotechnologies Corporation Information
12.17.2 immatics biotechnologies Description and Business Overview
12.17.3 immatics biotechnologies Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 immatics biotechnologies Products Offered
12.17.5 immatics biotechnologies Recent Development
12.18 Immunicum
12.18.1 Immunicum Corporation Information
12.18.2 Immunicum Description and Business Overview
12.18.3 Immunicum Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Immunicum Products Offered
12.18.5 Immunicum Recent Development
12.19 Ono Pharmaceutical
12.19.1 Ono Pharmaceutical Corporation Information
12.19.2 Ono Pharmaceutical Description and Business Overview
12.19.3 Ono Pharmaceutical Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Ono Pharmaceutical Products Offered
12.19.5 Ono Pharmaceutical Recent Development
12.20 Onyx Therapeutics
12.20.1 Onyx Therapeutics Corporation Information
12.20.2 Onyx Therapeutics Description and Business Overview
12.20.3 Onyx Therapeutics Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Onyx Therapeutics Products Offered
12.20.5 Onyx Therapeutics Recent Development
12.21 Oxford BioMedica
12.21.1 Oxford BioMedica Corporation Information
12.21.2 Oxford BioMedica Description and Business Overview
12.21.3 Oxford BioMedica Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Oxford BioMedica Products Offered
12.21.5 Oxford BioMedica Recent Development
12.22 Prometheus Laboratories
12.22.1 Prometheus Laboratories Corporation Information
12.22.2 Prometheus Laboratories Description and Business Overview
12.22.3 Prometheus Laboratories Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Prometheus Laboratories Products Offered
12.22.5 Prometheus Laboratories Recent Development
12.23 Seattle Genetics
12.23.1 Seattle Genetics Corporation Information
12.23.2 Seattle Genetics Description and Business Overview
12.23.3 Seattle Genetics Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Seattle Genetics Products Offered
12.23.5 Seattle Genetics Recent Development
12.24 Taiwan Liposome
12.24.1 Taiwan Liposome Corporation Information
12.24.2 Taiwan Liposome Description and Business Overview
12.24.3 Taiwan Liposome Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Taiwan Liposome Products Offered
12.24.5 Taiwan Liposome Recent Development
12.25 Tracon Pharmaceuticals
12.25.1 Tracon Pharmaceuticals Corporation Information
12.25.2 Tracon Pharmaceuticals Description and Business Overview
12.25.3 Tracon Pharmaceuticals Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Tracon Pharmaceuticals Products Offered
12.25.5 Tracon Pharmaceuticals Recent Development
12.26 Wilex
12.26.1 Wilex Corporation Information
12.26.2 Wilex Description and Business Overview
12.26.3 Wilex Kidney Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Wilex Products Offered
12.26.5 Wilex Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Kidney Cancer Drugs Industry Trends
13.2 Kidney Cancer Drugs Market Drivers
13.3 Kidney Cancer Drugs Market Challenges
13.4 Kidney Cancer Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Kidney Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Kidney Cancer Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Angiogenesis Inhibitors
Table 3. Major Manufacturers of mTOR Inhibitors
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Cytokine Immunotherapy (IL-2)
Table 6. Global Kidney Cancer Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Kidney Cancer Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Kidney Cancer Drugs Sales by Regions (2016-2021) & (K Units)
Table 9. Global Kidney Cancer Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Kidney Cancer Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Kidney Cancer Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Kidney Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Kidney Cancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Kidney Cancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Kidney Cancer Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Kidney Cancer Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Kidney Cancer Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Kidney Cancer Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Kidney Cancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Kidney Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Kidney Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Drugs as of 2020)
Table 22. Key Manufacturers Kidney Cancer Drugs Price (2016-2021) (USD/Unit)
Table 23. Kidney Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Kidney Cancer Drugs Product Type
Table 25. Date of International Manufacturers Enter into Kidney Cancer Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Kidney Cancer Drugs Sales by Type (2016-2021) (K Units)
Table 28. Global Kidney Cancer Drugs Sales Share by Type (2016-2021)
Table 29. Global Kidney Cancer Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Kidney Cancer Drugs Revenue Share by Type (2016-2021)
Table 31. Kidney Cancer Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global Kidney Cancer Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Kidney Cancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Kidney Cancer Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Kidney Cancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Kidney Cancer Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Kidney Cancer Drugs Sales by Application (2016-2021) (K Units)
Table 38. Global Kidney Cancer Drugs Sales Share by Application (2016-2021)
Table 39. Global Kidney Cancer Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Kidney Cancer Drugs Revenue Share by Application (2016-2021)
Table 41. Kidney Cancer Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global Kidney Cancer Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Kidney Cancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Kidney Cancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Kidney Cancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Kidney Cancer Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. United States Kidney Cancer Drugs Sales (K Units) of Key Companies (2016-2021)
Table 48. United States Kidney Cancer Drugs Sales Share by Company (2016-2021)
Table 49. United States Kidney Cancer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Kidney Cancer Drugs Revenue Share by Company (2016-2021)
Table 51. United States Kidney Cancer Drugs Sales (K Units) by Type (2016-2021)
Table 52. United States Kidney Cancer Drugs Sales Share by Type (2016-2021)
Table 53. United States Kidney Cancer Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Kidney Cancer Drugs Price (USD/Unit) by Type (2016-2021)
Table 55. United States Kidney Cancer Drugs Sales (K Units) by Type (2022-2027)
Table 56. United States Kidney Cancer Drugs Sales Share by Type (2022-2027)
Table 57. United States Kidney Cancer Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Kidney Cancer Drugs Revenue Share by Type (2022-2027)
Table 59. United States Kidney Cancer Drugs Price (USD/Unit) by Type (2022-2027)
Table 60. United States Kidney Cancer Drugs Sales (K Units) by Application (2016-2021)
Table 61. United States Kidney Cancer Drugs Sales Share by Application (2016-2021)
Table 62. United States Kidney Cancer Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Kidney Cancer Drugs Price (USD/Unit) by Application (2016-2021)
Table 64. United States Kidney Cancer Drugs Sales (K Units) by Application (2022-2027)
Table 65. United States Kidney Cancer Drugs Sales Share by Application (2022-2027)
Table 66. United States Kidney Cancer Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Kidney Cancer Drugs Revenue Share by Application (2022-2027)
Table 68. United States Kidney Cancer Drugs Price (USD/Unit) by Application (2022-2027)
Table 69. North America Kidney Cancer Drugs Sales by Country (2016-2021) & (K Units)
Table 70. North America Kidney Cancer Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Kidney Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Kidney Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Kidney Cancer Drugs Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Kidney Cancer Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Kidney Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Kidney Cancer Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Kidney Cancer Drugs Sales by Country (2016-2021) & (K Units)
Table 78. Europe Kidney Cancer Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Kidney Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Kidney Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Kidney Cancer Drugs Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Kidney Cancer Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Kidney Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Kidney Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Kidney Cancer Drugs Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Kidney Cancer Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Kidney Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Kidney Cancer Drugs Revenue Market Share by Country (2016-2021)
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Business Overview
Table 91. Bayer Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Bayer Kidney Cancer Drugs Product
Table 93. Bayer Recent Development
Table 94. Roche Corporation Information
Table 95. Roche Description and Business Overview
Table 96. Roche Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Roche Product
Table 98. Roche Recent Development
Table 99. GlaxoSmithKline Corporation Information
Table 100. GlaxoSmithKline Description and Business Overview
Table 101. GlaxoSmithKline Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. GlaxoSmithKline Product
Table 103. GlaxoSmithKline Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Business Overview
Table 106. Novartis Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Business Overview
Table 111. Pfizer Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Pfizer Product
Table 113. Pfizer Recent Development
Table 114. Abbott Laboratories Corporation Information
Table 115. Abbott Laboratories Description and Business Overview
Table 116. Abbott Laboratories Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. Abbott Laboratories Product
Table 118. Abbott Laboratories Recent Development
Table 119. Active Biotech Corporation Information
Table 120. Active Biotech Description and Business Overview
Table 121. Active Biotech Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Active Biotech Product
Table 123. Active Biotech Recent Development
Table 124. Amgen Corporation Information
Table 125. Amgen Description and Business Overview
Table 126. Amgen Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Amgen Product
Table 128. Amgen Recent Development
Table 129. Argos Therapeutics Corporation Information
Table 130. Argos Therapeutics Description and Business Overview
Table 131. Argos Therapeutics Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. Argos Therapeutics Product
Table 133. Argos Therapeutics Recent Development
Table 134. ArQule Corporation Information
Table 135. ArQule Description and Business Overview
Table 136. ArQule Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. ArQule Product
Table 138. ArQule Recent Development
Table 139. AVEO Pharmaceuticals Corporation Information
Table 140. AVEO Pharmaceuticals Description and Business Overview
Table 141. AVEO Pharmaceuticals Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 142. AVEO Pharmaceuticals Product
Table 143. AVEO Pharmaceuticals Recent Development
Table 144. Bionomics Corporation Information
Table 145. Bionomics Description and Business Overview
Table 146. Bionomics Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Bionomics Product
Table 148. Bionomics Recent Development
Table 149. Bristol-Myers Squibb Corporation Information
Table 150. Bristol-Myers Squibb Description and Business Overview
Table 151. Bristol-Myers Squibb Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Bristol-Myers Squibb Product
Table 153. Bristol-Myers Squibb Recent Development
Table 154. Cerulean Pharma Corporation Information
Table 155. Cerulean Pharma Description and Business Overview
Table 156. Cerulean Pharma Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 157. Cerulean Pharma Product
Table 158. Cerulean Pharma Recent Development
Table 159. Exelixis Corporation Information
Table 160. Exelixis Description and Business Overview
Table 161. Exelixis Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 162. Exelixis Product
Table 163. Exelixis Recent Development
Table 164. Genentech Corporation Information
Table 165. Genentech Description and Business Overview
Table 166. Genentech Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 167. Genentech Product
Table 168. Genentech Recent Development
Table 169. immatics biotechnologies Corporation Information
Table 170. immatics biotechnologies Description and Business Overview
Table 171. immatics biotechnologies Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 172. immatics biotechnologies Product
Table 173. immatics biotechnologies Recent Development
Table 174. Immunicum Corporation Information
Table 175. Immunicum Description and Business Overview
Table 176. Immunicum Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 177. Immunicum Product
Table 178. Immunicum Recent Development
Table 179. Ono Pharmaceutical Corporation Information
Table 180. Ono Pharmaceutical Description and Business Overview
Table 181. Ono Pharmaceutical Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 182. Ono Pharmaceutical Product
Table 183. Ono Pharmaceutical Recent Development
Table 184. Onyx Therapeutics Corporation Information
Table 185. Onyx Therapeutics Description and Business Overview
Table 186. Onyx Therapeutics Kidney Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 187. Onyx Therapeutics Product
Table 188. Onyx Therapeutics Recent Development
Table 189. Oxford Bi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs